Definitive Contract 75D30126C20752
- Not listed
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a $96,830 firm fixed-price purchase order to Distillersr Inc. for distillers licenses, with a completion date of November 21, 2028. This contract, awarded on November 21, 2023, requires no set-aside designation and represents a full and open competition award. The place of performance is located in Ottawa, Ontario, Canada, where Distillersr Inc., a Kanata-based software company, maintains operations. Distillersr Inc. is a...
- The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a firm-fixed price purchase order to Distillersr Inc., a global leader in AI-enabled literature review automation software, for its DistillerSR platform. The $72,175.66 contract, with an expiration date of April 25, 2024, will provide the CDC with access to DistillerSR, which streamlines the literature review process for research organizations. Distillersr Inc. has been awarded numerous...
- This is a federal contract award to Distillersr Inc., a for-profit limited liability company, by the Centers for Disease Control and Prevention (CDC) for the provision of its DistillerSR software and related subscriptions and services. The contract, valued at $51,044.53, is a firm fixed-price purchase order with an ultimate completion date of April 11, 2028. Distillersr Inc. is a global leader in AI-enabled literature review automation and evidence management software, and this award supports...
- The Food and Drug Administration awarded an $64,926 firm fixed-price purchase order to Distillersr Inc., a Canadian-based software company specializing in AI-enabled literature review automation and evidence management solutions. This contract, posted on August 3, 2021 and awarded on August 9, 2021, procures licenses for the DistillerSR Pro project management software platform with an ultimate completion date of August 8, 2026. The award utilized full and open competition with no set-aside...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh facility awarded a firm fixed-price purchase order to Clarivate Analytics (US) LLC for an EndNote Software License on June 1, 2022, with a ceiling value of $193,471.45 and completion date of November 30, 2025. This contract, which received no set-aside designation, provides the CDC with access to EndNote, a widely-used bibliographic management and citation tool that supports researchers in organizing references, managing...
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $86,313 purchase order to Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. Medical Imaging, LLC, for laboratory supplies. The firm fixed price contract runs from July 12, 2023 to October 13, 2023 for delivery of the requested products to the CDC location in Shelton, Connecticut. No subcontractors or set aside designations were identified. The award provides supplies to...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a $284,847.50 firm fixed-price purchase order to Protein Metrics, LLC on September 1, 2023, with an ultimate completion date of August 31, 2028. This contract, which carries no set-aside designation, procures software licenses and protein analytics services from the vendor, a specialized provider of vendor-neutral software for mass spectrometry-based protein analysis. Protein Metrics' solutions enable advanced analytical...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price Purchase Order contract to Strategic Innovative Solutions LLC (SIS), a minority-owned, small disadvantaged business, for $56,141.86. The contract is for engineering services and has an ultimate completion date of February 12, 2025. This award is a sole source 8(a) set-aside contract, leveraging SIS's status as a certified 8(a) and HUBZone firm. The contract supports the CDC's Pittsburgh office and is part of...
- This is a $1,947,900.24 definitive, firm fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) to Bevera Solutions LLC, an 8(a) certified, minority-owned, veteran-owned small business. The contract is for writer/editor professional support services, with modifications to include COVID-19 protocols. The contract has a period of performance ending on September 13, 2026. Bevera Solutions LLC is also the holder of a $45 million multiple-award...
- <p>The U.S. Centers for Disease Control and Prevention (CDC) awarded a $2,866,012.50 firm fixed-price purchase order to Seqera Labs S.l., a for-profit organization, for a software license. The award, which does not have a set-aside designation, has a period of performance through September 20, 2026. The contract was awarded on September 22, 2023. No additional details about a larger vehicle or subcontractors were provided.</p>
The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a definitive contract to Distillersr Inc. for a DistillerSR license on December 15, 2025, with a ceiling value of $86,226. The firm fixed price contract, which involves no set-aside designation, will be performed in Atlanta, Georgia and is scheduled for completion by December 14, 2030. Distillersr Inc., a Canadian-based limited liability company specializing in AI-enabled literature review automation and evidence management software, provides web-based subscription services designed to support systematic review processes and evidence-based research activities across federal agencies. The DistillerSR platform enables government organizations to efficiently manage, screen, and analyze scientific literature and research data—capabilities that align with the CDC's public health mission and research support functions. Distillersr Inc. has established a track record of federal contracting with multiple civilian agencies including the FDA, CPSC, VA, and Department of Agriculture, with contract values typically ranging from approximately $14,000 to $138,000. The company's software solutions support critical decision-making processes in public health, regulatory compliance, and chemical safety assessments, making this license award consistent with the CDC's systematic review and evidence evaluation requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.6k | 12/15/25 |